Literature DB >> 21813850

Adverse events after mass azithromycin treatments for trachoma in Ethiopia.

Berhan Ayele1, Teshome Gebre, Jenafir I House, Zhaoxia Zhou, Charles E McCulloch, Travis C Porco, Bruce D Gaynor, Paul M Emerson, Thomas M Lietman, Jeremy D Keenan.   

Abstract

During a cluster-randomized clinical trial for trachoma in Ethiopia, two rounds of adverse event surveillance were performed in a random sample of communities after community-wide mass azithromycin treatment. The prevalence of any reported adverse event ranged from 4.9% to 7.0% in children 1-9 years of age and from 17.0% to 18.7% in persons ≥ 10 years of age. Adverse events appeared to cluster by household and perhaps by village. Mass azithromycin distributions were well tolerated in this setting.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21813850      PMCID： PMC3144828          DOI： 10.4269/ajtmh.2011.11-0056

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


  18 in total

1.  Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.

Authors:  Sheila K West; Beatriz Munoz; Harran Mkocha; Charlotte Gaydos; Thomas Quinn
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-04       Impact factor: 4.799

2.  Mass treatment with single-dose azithromycin for trachoma.

Authors:  Anthony W Solomon; Martin J Holland; Neal D E Alexander; Patrick A Massae; Aura Aguirre; Angels Natividad-Sancho; Sandra Molina; Salesia Safari; John F Shao; Paul Courtright; Rosanna W Peeling; Sheila K West; Robin L Bailey; Allen Foster; David C W Mabey
Journal:  N Engl J Med       Date:  2004-11-04       Impact factor: 91.245

3.  Randomised controlled trial of single-dose azithromycin in treatment of trachoma.

Authors:  R L Bailey; P Arullendran; H C Whittle; D C Mabey
Journal:  Lancet       Date:  1993-08-21       Impact factor: 79.321

4.  Single-dose azithromycin prevents trichiasis recurrence following surgery: randomized trial in Ethiopia.

Authors:  Sheila K West; Emily S West; Wondu Alemayehu; Muluken Melese; Beatriz Munoz; Alemush Imeru; Alemayehu Worku; Charlotte Gaydos; Curtis L Meinert; Thomas Quinn
Journal:  Arch Ophthalmol       Date:  2006-03

5.  Brief communication: Better ways to question patients about adverse medical events: a randomized, controlled trial.

Authors:  Stephen Bent; Amy Padula; Andrew L Avins
Journal:  Ann Intern Med       Date:  2006-02-21       Impact factor: 25.391

6.  A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group.

Authors:  D H Martin; T F Mroczkowski; Z A Dalu; J McCarty; R B Jones; S J Hopkins; R B Johnson
Journal:  N Engl J Med       Date:  1992-09-24       Impact factor: 91.245

7.  Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments.

Authors:  Muluken Melese; Jaya Devi Chidambaram; Wondu Alemayehu; David Chung Lee; Elizabeth H Yi; Vicky Cevallos; Zhaoxia Zhou; Cathy Donnellan; Michael Saidel; John P Whitcher; Bruce D Gaynor; Thomas M Lietman
Journal:  JAMA       Date:  2004-08-11       Impact factor: 56.272

Review 8.  Macrolides and ketolides: azithromycin, clarithromycin, telithromycin.

Authors:  Jerry M Zuckerman
Journal:  Infect Dis Clin North Am       Date:  2004-09       Impact factor: 5.982

9.  Single-dose azithromycin in the treatment of trachoma. A randomized, controlled study.

Authors:  K F Tabbara; A Abu-el-Asrar; O al-Omar; A H Choudhury; Z al-Faisal
Journal:  Ophthalmology       Date:  1996-05       Impact factor: 12.079

10.  Effects of azithromycin on malariometric indices in The Gambia.

Authors:  S T Sadiq; K W Glasgow; C J Drakeley; O Muller; B M Greenwood; D C Mabey; R L Bailey
Journal:  Lancet       Date:  1995-09-30       Impact factor: 79.321
View more
  14 in total

Review 1.  Ocular Chlamydia trachomatis infection: elimination with mass drug administration.

Authors:  Meraf A Wolle; Sheila K West
Journal:  Expert Rev Anti Infect Ther       Date:  2019-02-18       Impact factor: 5.091

Review 2.  Trachoma.

Authors:  Anthony W Solomon; Matthew J Burton; Emily W Gower; Emma M Harding-Esch; Catherine E Oldenburg; Hugh R Taylor; Lamine Traoré
Journal:  Nat Rev Dis Primers       Date:  2022-05-26       Impact factor: 52.329

Review 3.  Trachoma: an update on prevention, diagnosis, and treatment.

Authors:  Satasuk Joy Bhosai; Robin L Bailey; Bruce D Gaynor; Thomas M Lietman
Journal:  Curr Opin Ophthalmol       Date:  2012-07       Impact factor: 3.761

4.  Coverage of azithromycin mass treatment for trachoma elimination in Northwestern Ethiopia: a community based cross-sectional study.

Authors:  Zelalem Tilahun; Teferi Gedif Fenta
Journal:  BMC Ophthalmol       Date:  2018-08-06       Impact factor: 2.209

5.  Self-Reported Side Effects following Mass Administration of Azithromycin to Eliminate Trachoma in Amhara, Ethiopia: Results from a Region-Wide Population-Based Survey.

Authors:  Tigist Astale; Eshetu Sata; Mulat Zerihun; Andrew W Nute; Aisha E P Stewart; Melsew Chanyalew; Berhanu Melak; Zebene Ayele; Demelash Gessese; Gedefaw Ayenew; Bizuayehu Gashaw; Zerihun Tadesse; Elizabeth Kelly Callahan; Scott D Nash
Journal:  Am J Trop Med Hyg       Date:  2019-03       Impact factor: 2.345

6.  Linear growth in preschool children treated with mass azithromycin distributions for trachoma: A cluster-randomized trial.

Authors:  Jeremy D Keenan; Sintayehu Gebresillasie; Nicole E Stoller; Berhan A Haile; Zerihun Tadesse; Sun Y Cotter; Kathryn J Ray; Kristen Aiemjoy; Travis C Porco; E Kelly Callahan; Paul M Emerson; Thomas M Lietman
Journal:  PLoS Negl Trop Dis       Date:  2019-06-05

7.  A double-masked placebo-controlled trial of azithromycin to prevent child mortality in Burkina Faso, West Africa: Community Health with Azithromycin Trial (CHAT) study protocol.

Authors:  Ali Sié; Mamadou Ouattara; Mamadou Bountogo; Cheik Bagagnan; Boubacar Coulibaly; Valentin Boudo; Elodie Lebas; Jessica M Brogdon; Ying Lin; Till Bärnighausen; Travis C Porco; Thuy Doan; Thomas M Lietman; Catherine E Oldenburg
Journal:  Trials       Date:  2019-12-04       Impact factor: 2.279

8.  A cluster randomized study of the safety of integrated treatment of trachoma and lymphatic filariasis in children and adults in Sikasso, Mali.

Authors:  Yaya Ibrahim Coulibaly; Ilo Dicko; Modibo Keita; Mahamadou Minamba Keita; Moussa Doumbia; Adama Daou; Fadima Cheick Haidara; Moussa Hama Sankare; John Horton; Caroline Whately-Smith; Samba Ousmane Sow
Journal:  PLoS Negl Trop Dis       Date:  2013-05-09

9.  A cluster-randomized controlled trial evaluating the effects of mass azithromycin treatment on growth and nutrition in Niger.

Authors:  Abdou Amza; Boubacar Kadri; Baido Nassirou; Nicole E Stoller; Sun N Yu; Zhaoxia Zhou; Sheila K West; David C W Mabey; Robin L Bailey; Jeremy D Keenan; Travis C Porco; Thomas M Lietman; Bruce D Gaynor
Journal:  Am J Trop Med Hyg       Date:  2012-12-03       Impact factor: 2.345

10.  Does mass azithromycin distribution impact child growth and nutrition in Niger? A cluster-randomized trial.

Authors:  Abdou Amza; Sun N Yu; Boubacar Kadri; Baido Nassirou; Nicole E Stoller; Zhaoxia Zhou; Sheila K West; Robin L Bailey; Bruce D Gaynor; Jeremy D Keenan; Travis C Porco; Thomas M Lietman
Journal:  PLoS Negl Trop Dis       Date:  2014-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.